(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 2. Reduced proliferation of sympatho-adrenal precursor cells causes a
smaller size of primary sympathetic ganglia in Insm1 mutant mice.
Phox2b and β-galactosidase expression was analyzed in the sympathetic
ganglion chain at E10.5 (A-F), E11.5 (G-J) and E12.5
(K-N) of Insm1lacZ/+ and
Insm1lacZ/Insm1lacZ mice by in situ
hybridization or immunohistochemical analyses. (A,B,G,H,K,L) In situ
hybridization using a Phox2b-specific probe. (C-F,I,J,M,N)
Immunohistochemistry using antibodies against (C-F,I,J,M,N)
β-galactosidase (green) and (E,F) Phox2b (red). The number of cells in
the primary sympathetic ganglion chain is reduced in the mutant at E11.5 and
E12.5. (O) Cell proliferation, as determined by BrdU injections at the
indicated time points in the primary sympathetic ganglion chain of
Insm1lacZ/+ and
Insm1lacZ/Insm1lacZ mice. Shown is the
proportion (%) of β-galactosidase+ cells that had incorporated BrdU 2
hours after the injection. Double asterisks indicate P<0.01. Scale
bars: 100 µm in A,G,K.